TY - JOUR
T1 - Synthesis and evaluation of a novel gene reporter molecule
T2 - detection of beta-galactosidase activity using 19F NMR of a fluorinated vitamin B6 conjugate+.
AU - Yu, Jianxin
AU - Ma, Zhenyi
AU - Li, Yingming
AU - Koeneman, Kenneth S.
AU - Liu, L.
AU - Mason, Ralph P.
PY - 2005/5
Y1 - 2005/5
N2 - Gene therapy has emerged as a promising strategy for treatment of various diseases. However, widespread implementation is hampered by difficulties in assessing the success of transfection, in particular, the spatial extent of expression in the target tissue and the longevity of expression. Thus, the development of non-invasive reporter techniques based on appropriate molecules and imaging modalities may help to assay gene expression. We now report the design, synthesis and evaluation of a novel in vivo gene transfection reporter molecule 3-O-(beta-D-galactopyranosyl)-6-fluoropyridoxol (GFPOL) using fluorinated vitamin B(6) as the (19)F NMR sensitive aglycone. GFPOL exhibits the following strengths as an in vivo (19)F NMR gene expression reporter: (a) large chemical shift response to enzyme cleavage (Deltadelta=8.00 ppm); (b) minimal toxicity for substrate or aglycone; (c) good water solubility; (d) good blood stability; (e) pH responsiveness of aglycone.
AB - Gene therapy has emerged as a promising strategy for treatment of various diseases. However, widespread implementation is hampered by difficulties in assessing the success of transfection, in particular, the spatial extent of expression in the target tissue and the longevity of expression. Thus, the development of non-invasive reporter techniques based on appropriate molecules and imaging modalities may help to assay gene expression. We now report the design, synthesis and evaluation of a novel in vivo gene transfection reporter molecule 3-O-(beta-D-galactopyranosyl)-6-fluoropyridoxol (GFPOL) using fluorinated vitamin B(6) as the (19)F NMR sensitive aglycone. GFPOL exhibits the following strengths as an in vivo (19)F NMR gene expression reporter: (a) large chemical shift response to enzyme cleavage (Deltadelta=8.00 ppm); (b) minimal toxicity for substrate or aglycone; (c) good water solubility; (d) good blood stability; (e) pH responsiveness of aglycone.
UR - http://www.scopus.com/inward/record.url?scp=28844453976&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=28844453976&partnerID=8YFLogxK
U2 - 10.2174/1573406053765495
DO - 10.2174/1573406053765495
M3 - Article
C2 - 16787321
AN - SCOPUS:28844453976
SN - 1573-4064
VL - 1
SP - 255
EP - 262
JO - Medicinal chemistry
JF - Medicinal chemistry
IS - 3
ER -